Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of 3,4-Dihydroxyphenylacetic acid in preparing antitumor drug

A technology for high altitude catechin and uses, which is applied in the field of antitumor drugs and can solve the problems of unclear toxic components and the like

Inactive Publication Date: 2013-12-04
JINGPENGHUI PHARMA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, its specific toxic components are not clear, and the relationship between the toxic components and active components of Xanthophylla remains to be further studied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3,4-Dihydroxyphenylacetic acid in preparing antitumor drug
  • Application of 3,4-Dihydroxyphenylacetic acid in preparing antitumor drug
  • Application of 3,4-Dihydroxyphenylacetic acid in preparing antitumor drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1 Effect of high protocatechuic acid on tumor cell and normal cell proliferation

[0035] Experimental scheme: using thiazolium blue (3-(4,5-dimethylthiazole-2)-2,5-diphenyltetrazolium bromide, MTT) experiment, plateau catechin (DO) (dose gradient of 10mg / ml, 1mg / ml, 100μg / ml, 10μg / ml, 1μg / ml, 100ng / ml) to treat lung cancer cell A549, lung cancer cell LLC, Wilms tumor cell G401, nasopharyngeal cancer cell CNE2Z and laryngeal cancer cell Hep2, rhabdomyosarcoma cell A204, breast cancer cell MDA231, breast cancer cell T47D, breast cancer cell MCF7, pancreatic cancer cell PANC1, neuroblastoma cell SY5Y and cervical cancer cell Hela for 24 hours, MTT staining for 4 hours, DMSO (DMSO) was dissolved, and the absorbance value was measured at 570nm by a microplate reader. With the compound gradient as the abscissa and the cell viability as the ordinate, draw a standard curve and calculate the half inhibitory concentration IC 50 , see Table 1 for the specific results.

...

Embodiment 2

[0039] Example 2 In vitro anti-tumor cell migration effect of plateau catechin

[0040] Experimental program:

[0041] 1) Using cell migration assay (Transwell) experiment, 20 μg / ml high protocatechuic acid (DO) (safe dose) to treat lung cancer cells LLC, lung cancer cells (A549), cervical cancer cells Hela, neuroblastoma cells SY5Y, breast cancer cells Cell MCF7, breast cancer cell MDA231, breast cancer cell T47D, rhabdomyosarcoma cell A204, Wilms tumor cell G401, skin squamous cell carcinoma cell A431, nasopharyngeal carcinoma cell CNE2Z and laryngeal carcinoma cell Hep224 hours later, anhydrous ice methanol fixation 20 Minutes, then stained with crystal violet for 15 minutes, and photographed with a 100-fold light microscope to detect the number of cell migration.

[0042] 2) Using cell migration assay (Scratch Analysis) experiment, 20μg / ml high protocatechuic acid (DO) (safe dose) to treat lung cancer cells (LLC), lung cancer cells (A549), cervical cancer cells (Hela), ne...

Embodiment 3

[0047] Example 3 Effect of high protocatechuic acid on tumor cell apoptosis

[0048] Experimental protocol: Apoptotic flow cytometry assay was used. Human lung cancer cells (A549), Wilms tumor cells (G401) and laryngeal carcinoma cells (Hep2) were treated with 10 μM high catechin (DO) for 24 hours, and collected by centrifugation Cells (1500rpm, 5min), resuspended in PBS and centrifuged for 2 times, then stained with Annexin-V FITC and PI for 15min respectively, the percentage of apoptotic cells, the sum of the percentages of early apoptotic cells and late apoptotic cells were detected by flow cytometry and the total ratio of apoptosis.

[0049] Experimental results: Higher catechin (DO) can significantly promote the apoptosis of A549, G401 and Hep2 cells, suggesting that higher level catechin (DO) may play an anti-tumor effect by mediating the apoptosis of tumor cells. For specific results, see image 3 A-3C.

[0050] The above in vitro anti-tumor experiment results show t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Volumeaaaaaaaaaa
Sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides application of 3,4-Dihydroxyphenylacetic acid or pharmaceutically acceptable salt, solvate or polycrystalin in preparation of drugs for preventing and / or treating tumor. According to experiments in vivo and in vitro, the 3,4-Dihydroxyphenylacetic acid has the efficacy of suppressing various tumors, including lung cancer, breast cancer, cervical cancer, nephroblastoma, nasopharynx cancer, laryngeal carcinoma, neuroblastoma and the like, and has a broad-spectrum antitumor function. The compound is derived from natural drugs, and is expected to become a new selection for clinical trials treatment.

Description

technical field [0001] The invention belongs to the field of antitumor drugs, and in particular relates to the use of high protocatechuic acid in the preparation of antitumor drugs. Background technique [0002] Tumor is a new organism formed by the body under the action of various carcinogenic factors, cells lose normal regulation of their growth at the gene level, resulting in abnormal clonal proliferation, manifested as a tumor. Tumor cells are different from normal cells in terms of external morphology, metabolism and function, and most of them present continuous proliferation. According to available statistics, tumor is the first of the three major factors threatening human life and health all over the world, so the research and development of anti-tumor drugs has become a hot spot in recent years. [0003] According to the traditional classification and research progress of antineoplastic drugs, commonly used antineoplastic drugs can be divided into the following cate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/192A61P35/00
CPCA61K31/192A61P35/00
Inventor 李梢
Owner JINGPENGHUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com